Intraday calls for 22-11-10
Markets likely to open gap up. Support for nifty is at 5850 and resistance at 5970.
On rise one can short Tata steel near 615-620 levels with stoploss at 630.
Avoid fresh longs for now. Nifty looks weak below important support of 6000-6030. Please refer to the below nifty chart. (click on image to enlarge)
SMS Alerts, no more page refreshes required
439 Responses
{ ADD YOUR OWN }Leave a Reply
Subscribe to Comments feedLatest Query
- by Sam
Search Our Archives
Research Desk
- Stocks Trading above their 50 day moving average - DMA In Stock Research
- Download free Ebooks based on Technical Analysis In Personal Training
- TOP 100 Stocks with the Highest P/E as on July 14th, 2013 In Stock Research
- TOP 100 Stocks with the Lowest P/E as on July 14th, 2013 In Stock Research
- Charting Pathsala - Your guide to Techincals In Technical Analysis
shipra Says:
November 22nd, 2010
Posted at: 8:58 am
hi cb...how much time do u think will my longs take to recover to reach my cost price..
possible in december pls?
vindi Says:
November 22nd, 2010
Posted at: 8:58 am
buy levels of tvs motors, sona koya , satyam .
CB Says:
November 22nd, 2010
Posted at: 8:59 am
Hi stocket, yes, dish can be bought today
new investor Says:
November 22nd, 2010
Posted at: 8:59 am
yes, i believe on you.
that is why again asking for you some tips....2 to 3 weeks
Arunava Says:
November 22nd, 2010
Posted at: 8:59 am
Dr Reddy's gets nod to launch Zafirlukast
Pharmaceutical major Dr Reddy's Laboratories has launched Zafirlukast tablets (10 mg and 20 mg), a bioequivalent generic version of Accolate in the US market.
Zafirlukast is a prescription medicine used for treating asthma. According to IMS Health, the medicine had total US sales of approximately $50 million for the 12 months ending August 31, 2010.
On November 15, 2010, the US District Court of New Jersey granted Dr Reddy's motion for summary judgment of non-infringement against AstraZeneca clearing the way for the launch of the product.
Subsequently, the Food & Drug Administration (FDA) approved Dr Reddy's ANDA (abbreviated new drug application) for Zafirlukast tablets on November 18, the company stated in a press release here on Saturday.
The company's tablets are available in bottles of 60 counts.
NAZIR Says:
November 22nd, 2010
Posted at: 9:00 am
HI CB,
I hv TTL @44.50 and EXIDE IND @166.50. What will be todays target.
CB Says:
November 22nd, 2010
Posted at: 9:00 am
Hi Kb, Good morning
Hi shipra, yes, likely to be able to exit in december
Hi vindi, tvs is facing resistance near 80-93. satyam looks a bit weak. sona too is not a buy yet.
LEO Says:
November 22nd, 2010
Posted at: 9:01 am
Hi CB / Kartik,
Good Morning ..
Can we close our call and take fresh put today on rise ...
CB Says:
November 22nd, 2010
Posted at: 9:02 am
Hi new investor, thanks.. buy some of dish tv
Hi Arunava, thanks
Hi NAZIR, ttl can see 44. exide around 166
anoop Says:
November 22nd, 2010
Posted at: 9:02 am
INTRADAY:
BUY SASKEN COMMUNICATION..CMP 176..SL 173..TARGET 182
MURLI IND..CMP 78.30..TARGET 83..SL 76
CB Says:
November 22nd, 2010
Posted at: 9:02 am
Hi LEO, Good morning. yes
AJ Says:
November 22nd, 2010
Posted at: 9:04 am
CB,
How do you see KALE and REL MEDIA moving today?
CB Says:
November 22nd, 2010
Posted at: 9:04 am
Hi Manoj, yes, fundamentally look good. hold for short term.
vindi Says:
November 22nd, 2010
Posted at: 9:05 am
buy levels of unitech
CB Says:
November 22nd, 2010
Posted at: 9:06 am
Hi AJ, kale may remain flat. rel med can add 7-8rs
Manoj Says:
November 22nd, 2010
Posted at: 9:06 am
can i fresh buying for sail and syndicate bank and vidiocon any one stock for sugses me